Materialise receives a 'Buy' rating, driven by robust growth in its medical segment despite weakness in software and manufacturing. MTLS's medical segment boasts a 4-year CAGR of 16%, with management ...
Add Yahoo as a preferred source to see more of our stories on Google. The tiny point of a laser zipped back and forth inside a machine, laying down layer upon layer of polymer, creating what will ...
Stratasys PolyJet technology and Materialise FDA-cleared software now most versatile 3D printing system for hospitals and physicians to build anatomical models at the point-of-care MINNEAPOLIS & ...
Materialise ( (MTLS)) just unveiled an announcement. Materialise NV, a Belgium-based leader in 3D-printed medical devices and additive manufacturing software, serves healthcare, industrial and ...
The life sciences isn't a huge business for 3-D printing player Materialise ($MTLS)--but it's working to change that. Its latest move is a deal with Canon Lifecare ...
Further bringing 3D printed medical models to life, Stratasys is expanding the suite of printers and materials validated by its collaborator Materialise as part of FDA-cleared Materialise Mimics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results